Xenon Pharmaceuticals (NASDAQ:XENE) Earns Buy Rating from Analysts at Deutsche Bank Aktiengesellschaft
Equities research analysts at Deutsche Bank Aktiengesellschaft started coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) in a research report issued to clients and investors ...
Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) PT at $56.00
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been assigned an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat ...